Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long Non Coding RNA in Triple Negative Breast Cancer: A Promising Biomarker in Tumorigenesis. | Asian Pac J Cancer Prev | 2023 | 36708551 | PubTator, text mining | PubMed |
| Hypoxia-tolerant apical-out intestinal organoids to model host-microbiome interactions. | J Tissue Eng | 2023 | 36699634 | PubTator, text mining | PubMed |
| Peripheral Blood Gene Expression Profile of Infants with Atopic Dermatitis. | JID Innov | 2023 | 36699197 | PubTator, text mining | PubMed |
| Oncogenic ERRB2 signals through the AP-1 transcription factor to control mesenchymal-like properties of oesophageal adenocarcinoma. | NAR Cancer | 2023 | 36694726 | PubTator, text mining | PubMed |
| Rapid nuclear deadenylation of mammalian messenger RNA. | iScience | 2023 | 36691625 | PubTator, text mining | PubMed |
| Expansion of ventral foregut is linked to changes in the enhancer landscape for organ-specific differentiation. | Nat Cell Biol | 2023 | 36690849 | PubTator, text mining | PubMed |
| Traditional Chinese medicine for transformation of gastric precancerous lesions to gastric cancer: A critical review. | World J Gastrointest Oncol | 2023 | 36684050 | PubTator, text mining | PubMed |
| Single-nucleus RNA sequencing and deep tissue proteomics reveal distinct tumour microenvironment in stage-I and II cervical cancer. | J Exp Clin Cancer Res | 2023 | 36683048 | PubTator, text mining | PubMed |
| Absence of Scaffold Protein Tks4 Disrupts Several Signaling Pathways in Colon Cancer Cells. | Int J Mol Sci | 2023 | 36674824 | PubTator, text mining | PubMed |
| Role of Exosomes and Their Potential as Biomarkers in Epstein-Barr Virus-Associated Gastric Cancer. | Cancers (Basel) | 2023 | 36672418 | PubTator, text mining | PubMed |
| Chromatin and Cancer: Implications of Disrupted Chromatin Organization in Tumorigenesis and Its Diversification. | Cancers (Basel) | 2023 | 36672415 | PubTator, text mining | PubMed |
| Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth. | J Exp Clin Cancer Res | 2023 | 36670508 | PubTator, text mining | PubMed |
| Bioinformatics reveal elevated levels of Myosin Vb in uterine corpus endometrial carcinoma patients which correlates to increased cell metabolism and poor prognosis. | PLoS One | 2023 | 36662766 | PubTator, text mining | PubMed |
| Effect of mechanical unloading on genome-wide DNA methylation profile of the failing human heart. | JCI Insight | 2023 | 36656640 | PubTator, text mining | PubMed |
| Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma. | Nat Commun | 2023 | 36653361 | PubTator, text mining | PubMed |
| ETS1-HMGA2 Axis Promotes Human Limbal Epithelial Stem Cell Proliferation. | Invest Ophthalmol Vis Sci | 2023 | 36652264 | PubTator, text mining | PubMed |
| Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets. | Signal Transduct Target Ther | 2023 | 36646695 | PubTator, text mining | PubMed |
| Comparative analysis of genome-scale, base-resolution DNA methylation profiles across 580 animal species. | Nat Commun | 2023 | 36646694 | PubTator, text mining | PubMed |
| CircStrn3 targeting microRNA-9-5p is involved in the regulation of cartilage degeneration and subchondral bone remodelling in osteoarthritis. | Bone Joint Res | 2023 | 36642417 | PubTator, text mining | PubMed |
| SF3B4 promotes Twist1 expression and clear cell renal cell carcinoma progression by facilitating the export of KLF 16 mRNA from the nucleus to the cytoplasm. | Cell Death Dis | 2023 | 36639679 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=34